Sysplasma

The annual accounts of Sysplasma for fiscal year 2025 show a net loss of 52% of the equity at the start of that year. The 2025 annual accounts show equity of €21,577 and a net result of -€23,225. Equity is shrinking by ~6.9% per year across the filed fiscal years. Its solvency ranks better than 35% of 782 sector peers (NACE 74, fiscal year 2025). The company has been active since 2021 and the Belgian State Gazette contains no insolvency or warning signals. The computed 12-month bankruptcy probability is 1.3% (low).